Literature DB >> 22288427

Telomere length shortening in patients with dementia with Lewy bodies.

K Kume1, M Kikukawa, H Hanyu, Y Takata, T Umahara, H Sakurai, H Kanetaka, K Ohyashiki, J H Ohyashiki, T Iwamoto.   

Abstract

BACKGROUND AND
PURPOSE: Shortened telomere length has been considered to be associated with various age-related diseases, especially in dementia such as Alzheimer's disease and vascular dementia. However, changes in telomere length in dementia with Lewy bodies (DLB) remain unclear. To elucidate these changes, we set out to determine telomere length in peripheral leukocytes as well as the level of urinary 8-hydroxy-deoxyguanosine (8-OHdG) as a marker of oxidative stress in DLB.
METHODS: Blood samples were obtained from 33 patients with a clinical diagnosis of probable DLB and 35 age-matched, non-demented elderly controls (NEC). Telomere length was assessed by quantitative real-time polymerase chain reaction of genomic DNA extracted from leukocytes, whereas oxidative stress was assessed on the basis of urine 8-OHdG level, which was measured using high-performance liquid chromatography.
RESULTS: Telomere length was significantly shorter in the DLB group than in the NEC group. Urinary 8-OHdG levels were significantly higher in the DLB group than in the NEC group. There was a negative correlation between telomere length and age in the DLB group; however, there were no significant relationships between telomere length and clinical findings including disease duration, severity of cognitive decline, presence or absence of fluctuation in cognitive function, visual hallucinations, and Parkinsonism. In both groups, the correlation between telomere length and urinary 8-OHdG levels was not significant.
CONCLUSIONS: These findings indicate that the etiopathology of DLB is considered to be an accelerated aging process.
© 2012 The Author(s). European Journal of Neurology © 2012 EFNS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22288427     DOI: 10.1111/j.1468-1331.2011.03655.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  14 in total

1.  Neurodegeneration-associated instability of ribosomal DNA.

Authors:  Justin Hallgren; Maciej Pietrzak; Grzegorz Rempala; Peter T Nelson; Michal Hetman
Journal:  Biochim Biophys Acta       Date:  2014-01-02

2.  Telomere length and Parkinson's disease in men: a nested case-control study.

Authors:  M Schürks; J Buring; R Dushkes; J M Gaziano; R Y L Zee; T Kurth
Journal:  Eur J Neurol       Date:  2013-09-07       Impact factor: 6.089

3.  Telomere length and cognitive function: Differential patterns across sociodemographic groups.

Authors:  Daniel K Leibel; Danielle Shaked; Danielle L Beatty Moody; Hans B Liu; Nan-Ping Weng; Michele K Evans; Alan B Zonderman; Shari R Waldstein
Journal:  Neuropsychology       Date:  2019-10-14       Impact factor: 3.295

4.  Generating Late-Onset Human iPSC-Based Disease Models by Inducing Neuronal Age-Related Phenotypes through Telomerase Manipulation.

Authors:  Elsa Vera; Nazario Bosco; Lorenz Studer
Journal:  Cell Rep       Date:  2016-10-18       Impact factor: 9.423

5.  Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson's disease and Lewy body dementia.

Authors:  Muhammad Asghar; Amani Odeh; Ahmad Jouni Fattahi; Alexandra Edwards Henriksson; Aurelie Miglar; Shervin Khosousi; Per Svenningsson
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

6.  Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis.

Authors:  Debra Lyon; Lynne Elmore; Noran Aboalela; Jacqueline Merrill-Schools; Nancy McCain; Angela Starkweather; R K Elswick; Colleen Jackson-Cook
Journal:  Biol Res Nurs       Date:  2013-04-11       Impact factor: 2.522

7.  Soluble CD163 is associated with shortened telomere length in HIV-infected patients.

Authors:  Suman Srinivasa; Kathleen V Fitch; Eva Petrow; Tricia H Burdo; Kenneth C Williams; Janet Lo; Hélène C F Cȏté; Steven K Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

Review 8.  Early Life Epidemiology of Alzheimer's Disease--A Critical Review.

Authors:  Alon Seifan; Matthew Schelke; Yaa Obeng-Aduasare; Richard Isaacson
Journal:  Neuroepidemiology       Date:  2015-10-27       Impact factor: 3.282

Review 9.  Telomere shortening in neurological disorders: an abundance of unanswered questions.

Authors:  Erez Eitan; Emmette R Hutchison; Mark P Mattson
Journal:  Trends Neurosci       Date:  2014-03-31       Impact factor: 13.837

10.  Blood and dried blood spot telomere length measurement by qPCR: assay considerations.

Authors:  DeAnna L Zanet; Sara Saberi; Laura Oliveira; Beheroze Sattha; Izabella Gadawski; Hélène C F Côté
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.